Saxenda Vision Loss Lawsuit: A Pivotal Patient Update [2026]

This often occurs upon waking and typically affects only one eye. It is a hallmark symptom of NAION.

Saxenda and Floaters

Dark specks, strings, or cobweb-like shapes that “drift” across your field of vision. While common with age, a sudden increase in floaters can indicate bleeding in the eye or retinal detachment.

Saxenda and Eye floaters (spots/threads) and flashes (streaks of light) are common, often age-related, symptoms caused by the vitreous gel inside the eye shrinking and pulling on the retina (posterior vitreous detachment). While usually harmless, a sudden increase in floaters or flashes, especially with a dark curtain in vision, requires immediate medical attention to rule out a retinal tear or detachment.

Causes and Risk Factors

• Posterior Vitreous Detachment (PVD): The primary cause, where the gel-like vitreous shrinks, liquifies, and separates from the retina, common in people aged 40 to 80.

• Aging: As the body ages, collagen in the vitreous breaks down and clumps, forming floaters, while the shrinkage creates light-producing flashes.

• Retinal Tear/Detachment: A serious condition where the pulling vitreous tears the retina, requiring immediate treatment to prevent permanent Trulicity blindness

• Other Factors: Migraines, eye injury/trauma, and inflammation (vitritis) can also cause flashes.

POSSIBLE SIDE EFFECTS OF SAXENDA

Symptoms

Treatment and Management

When to Seek Immediate Care

• Peripheral Vision Loss: A “shadow” or dark curtain closing in from the sides or bottom of your vision, often associated with optic nerve injury.

• Eye Pain or Pressure: While Saxenda  and NAION is usually painless, persistent pain or a feeling of “fullness” behind the eye can signal acute glaucoma or severe inflammation.

• Loss of Color Perception: A new inability to see colors as brightly as before, or colors appearing “washed out” (dyschromatopsia).

Common Side Effects (Lower Case Value)

• Saxenda and Blurry Vision / Fluctuating Vision: Vision that shifts from clear to hazy throughout the day. On GLP-1 drugs, this is often a temporary result of rapid blood sugar changes changing the shape of the eye’s lens.

• Diabetic Retinopathy: Worsening of existing damage to blood vessels in the retina. While serious, many GLP-1 labels already mention this, making “failure to warn” claims more difficult for this specific condition compared to NAION.

The Link Between Saxenda and NAION

• Recent Clinical Investigations: Have identified a concerning association between GLP-1 receptor agonists, including Saxenda and elevated rates of NAION.

• Saxenda NAION Lawsuit:  A landmark study published in 2024 examined medical records from a large ophthalmology practice, revealing statistically significant increases in NAION incidence among patients prescribed these medications for type 2 diabetes and obesity management.

• Another study established a concerning connection between GLP-1 receptor agonists—including both Saxenda and Ozempic (semaglutide)—and increased incidence rates of NAION. Clinical observations have documented elevated occurrences of this condition among patients prescribed these medications compared to individuals using alternative diabetes treatments.

Recognizing the Mounjaro and NAION Risks

• Classic symptoms of NAION include sudden, painless loss of vision—usually upon waking up—in one eye.

• You might also notice other Saxenda and NAION eye side Effects  or a shadow or “curtain” over part of your visual field, decreased color perception, or difficulties adjusting to different lighting conditions.

• If you experience any of these symptoms while using Saxenda, seek emergency care from an ophthalmologist immediately.

Evidence of Saxenda and NAION Risks

The research documented NAION occurrence rates across distinct patient populations:

• Type 2 diabetes patients: Those prescribed semaglutide or tirzepatide demonstrated a 4.28-fold increased risk of developing NAION compared to patients using alternative diabetes medications.

• Obesity treatment cohorts: Individuals receiving GLP-1 drugs for weight management exhibited a 7.64-fold elevated risk relative to those prescribed other weight-loss interventions.

• Absolute incidence rates: The cumulative three-year probability of NAION development reached 8.9% among GLP-1 drug users versus 1.8% in comparison groups.

The Risk Factors for NAION

• Optic Nerve Anatomy: Having a naturally small or “crowded” optic disc (“disc-at-risk”). This is an unchangeable physical trait.

• Age: Most common in adults over 50

• High Blood Pressure (Hypertension): Especially if blood pressure drops too low overnight, sometimes because of medication taken at bedtime.

• Diabetes: Poorly controlled blood sugar and the associated blood vessel damage.

• Sleep Apnea: A condition where breathing stops temporarily during sleep. This is a significant risk factor, possibly due to changes in blood pressure and oxygen levels at night.

• Smoking: Damages blood vessels and is a strong risk factor.

• High Cholesterol (Hyperlipidemia): Contributes to hardening of the arteries (atherosclerosis).

• Certain Medications: The heart medicine amiodarone and some erectile dysfunction drugs (like Viagra, Cialis, Levitra) may be associated with NAION in at-risk individuals.

• Genetic Predisposition: Minor changes in genes related to blood flow control and clotting that can increase susceptibility in some cases.

• Chronic Vascular Effects:  Other risk factors may include the chronic vascular other risk factors may include the chronic vascular effects of anemia and kidney disease.

• Nocturnal hypotension: Significant drops in blood pressure during sleep can decrease blood flow to the optic nerve head.

• Individuals with obesity: Excess weight contributes to systemic inflammation and vascular dysfunction

• Patients with pre-existing cardiovascular conditions: Compromised circulation increases the likelihood of optic nerve ischemia

It is vital that you work with your primary care physician to identify and manage the well-established health risks to help prevent NAION in the other eye or a future vascular event like a heart attack or stroke.

Vision Injury Checklist & Definitions

• Saxenda and Eye Floaters (Vitreous Floaters): Small dark shapes, “spots,” or “cobwebs” that drift across your field of vision. A sudden onset can signal retinal tearing or bleeding caused by rapid eye pressure changes.

• Saxenda and NAION: Often called an “Eye Stroke.” It is a sudden, painless loss of vision in one eye caused by a lack of blood flow to the optic nerve. This is the “big” permanent injury at the center of 2026 litigation.

• Saxenda and Blurry Vision: A loss of sharpness that makes it hard to see fine details. While often temporary due to blood sugar shifts, persistent blurring can be a precursor to permanent damage.

• Flashes of Light (Photopsia): Seeing “lightning streaks” or sparks, especially in your peripheral vision. This is a major warning sign of a retinal detachment.

• Visual Field Loss: The feeling of a “curtain” or “shadow” falling over part of your vision. This is a medical emergency often linked to optic nerve damage.